- Home
- VRAX vs GCTK Comparison
VRAX vs GCTK Comparison
Compare VRAX & GCTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRAX | GCTK |
|---|---|---|
| Founded | 2013 | 2001 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7M | 1.6M |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | VRAX | GCTK |
|---|---|---|
| Price | $0.24 | $1.58 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | 162.7K | ★ 205.9K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17910.53 |
| EPS | N/A | ★ 30.09 |
| Revenue | N/A | ★ $589,462.00 |
| Revenue This Year | $217,274.83 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.05 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.20 | $0.09 |
| 52 Week High | $1.85 | $15.90 |
Technical Indicators
Market Signals| Indicator | VRAX | GCTK |
|---|---|---|
| Relative Strength Index (RSI) | 39.40 | 25.95 |
| Support Level | $0.20 | $1.52 |
| Resistance Level | $0.52 | $4.24 |
| Average True Range (ATR) | 0.02 | 0.13 |
| MACD | 0.00 | 0.07 |
| Stochastic Oscillator | 36.94 | 24.48 |
Price Performance
Historical ComparisonAbout VRAX Virax Biolabs Group Limited
Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.
About GCTK GlucoTrack Inc.
GlucoTrack Inc is a medical device company. It is focused on defining novel approaches that make diabetes management more accurate and convenient for daily living. The company has developed the GlucoTrack model that measures real-time blood glucose levels. The Company is developing an long-term implantable continuous blood glucose monitoring (CBGM) system, built on healthcare technologies. It is designed to meet the critical needs of insulin-dependent individuals or those at risk of hypoglycemia in the U.S.